Efficacy of Docetaxel (J 15) and Celecoxib in Metastatic Prostate Cancer
Efficacy of Docetaxel (J 15) and Celecoxib in Metastatic Prostate Cancer
Clinical response to chemotherapy. Biological parameter (PSA) and RECIST evaluation. Association of Docetaxel (J 15) and Celecoxib.
Association Docetaxel (J 15) and celecoxib Patient survival Biological parameter : PSA Clinical status RECIST evaluation
Inclusion Criteria:
Exclusion Criteria: